Florida Premier Research Institute

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Peripheral artery disease1 trial

Phase

• Phase 2/31 trial
• Phase 31 trial

Status

• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• CSL Behring1 trial
• Otsuka Pharmaceutical Development & Commercialization, Inc.1 trial

Running trials

• Recruiting

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· Phase 2/3· CSL Behring· Source

  Contact: Trial Registration Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Coronary artery disease1 recruiting
• Peripheral artery disease1 recruiting

Closed trials

• Terminated

  Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

  NCT02446132· Phase 3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source